JP2020535436A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020535436A5 JP2020535436A5 JP2020518048A JP2020518048A JP2020535436A5 JP 2020535436 A5 JP2020535436 A5 JP 2020535436A5 JP 2020518048 A JP2020518048 A JP 2020518048A JP 2020518048 A JP2020518048 A JP 2020518048A JP 2020535436 A5 JP2020535436 A5 JP 2020535436A5
- Authority
- JP
- Japan
- Prior art keywords
- fgf
- treatment
- subject
- 2sdng
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024064931A JP2024105273A (ja) | 2017-09-29 | 2024-04-12 | Ｆｇｆ－１８化合物に対する反応性を予測する代謝バイオマーカー |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17194220.4 | 2017-09-29 | ||
| EP17194220 | 2017-09-29 | ||
| EP18169324 | 2018-04-25 | ||
| EP18169324.3 | 2018-04-25 | ||
| PCT/EP2018/076395 WO2019063758A1 (en) | 2017-09-29 | 2018-09-28 | METABOLIC BIOMARKERS FOR PREDICTING RESPONSE TO FGF-18 COMPOUND |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024064931A Division JP2024105273A (ja) | 2017-09-29 | 2024-04-12 | Ｆｇｆ－１８化合物に対する反応性を予測する代謝バイオマーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020535436A JP2020535436A (ja) | 2020-12-03 |
| JP2020535436A5 true JP2020535436A5 (https=) | 2021-11-11 |
| JP7791649B2 JP7791649B2 (ja) | 2025-12-24 |
Family
ID=63722380
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020518048A Active JP7791649B2 (ja) | 2017-09-29 | 2018-09-28 | Ｆｇｆ－１８化合物に対する反応性を予測する代謝バイオマーカー |
| JP2024064931A Withdrawn JP2024105273A (ja) | 2017-09-29 | 2024-04-12 | Ｆｇｆ－１８化合物に対する反応性を予測する代謝バイオマーカー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024064931A Withdrawn JP2024105273A (ja) | 2017-09-29 | 2024-04-12 | Ｆｇｆ－１８化合物に対する反応性を予測する代謝バイオマーカー |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11513128B2 (https=) |
| EP (1) | EP3687558B1 (https=) |
| JP (2) | JP7791649B2 (https=) |
| CN (1) | CN111163791A (https=) |
| AU (1) | AU2018343982B2 (https=) |
| CA (1) | CA3076029A1 (https=) |
| DK (1) | DK3687558T3 (https=) |
| ES (1) | ES2918250T3 (https=) |
| HR (1) | HRP20220760T1 (https=) |
| HU (1) | HUE058786T2 (https=) |
| IL (1) | IL273613B2 (https=) |
| LT (1) | LT3687558T (https=) |
| PL (1) | PL3687558T3 (https=) |
| RS (1) | RS63293B1 (https=) |
| SI (1) | SI3687558T1 (https=) |
| WO (1) | WO2019063758A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016211950A1 (en) | 2015-01-29 | 2017-07-13 | Ares Trading S.A. | Immunoassays for high positively charged proteins |
| IL273613B2 (en) | 2017-09-29 | 2026-02-01 | Merck Patent Gmbh | Metabolic biomarkers for predicting response to FGF-18 compound |
| SI3688468T1 (sl) | 2017-09-29 | 2022-08-31 | Merck Patent Gmbh | Vnetni biomarkerji za predvidevanje odzivov na spojino FGF-18 |
| IL281333B2 (en) | 2018-09-10 | 2025-11-01 | Merck Patent Gmbh | A method for reducing risk in a clinical trial |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2339002A1 (en) | 1996-10-16 | 2011-06-29 | ZymoGenetics, Inc. | Fibroblast growth factor homologs |
| ES2493840T3 (es) | 2002-10-07 | 2014-09-12 | Zymogenetics, Inc. | Procedimiento de administración de FGF-18 |
| AU2003287697A1 (en) | 2002-11-08 | 2004-06-03 | Barnes-Jewish Hospital | Uncoupled collagen synthesis and degradation assays |
| AU2005314438B2 (en) | 2004-12-10 | 2012-03-29 | Zymogenetics, Inc. | FGF18 production in prokaryotic hosts |
| US8224579B2 (en) * | 2005-06-17 | 2012-07-17 | The Brigham And Women's Hospital, Inc. | Method of diagnosing osteoarthritis |
| US20070292982A1 (en) | 2006-06-16 | 2007-12-20 | Jeffery Gail Holloway | Method for Manufacturing Transparent Windows in Molded Semiconductor Packages |
| HRP20120643T1 (hr) | 2006-08-25 | 2012-08-31 | Ares Trading S.A. | Liječenje poremećaja hrskavice sa fgf-18 |
| JP2009257842A (ja) | 2008-04-14 | 2009-11-05 | Ttc:Kk | 変形性関節症の検査方法及び診断用キット |
| JP5762282B2 (ja) | 2008-05-02 | 2015-08-12 | インタールーキン ジェネティクス， インコーポレイテッド | 変形性関節症に関連する状態に対する遺伝的素因の検出 |
| US20090299769A1 (en) | 2008-05-29 | 2009-12-03 | Nordic Bioscience Imaging A/S | Prognostic osteoarthritis biomarkers |
| US20120115137A1 (en) | 2010-08-31 | 2012-05-10 | Kornman Kenneth S | Methods of Predicting Osteoarthritis |
| TWI527590B (zh) | 2011-06-17 | 2016-04-01 | 艾瑞斯貿易公司 | Ｆｇｆ－１８之凍乾調配物 |
| AU2013301607B2 (en) | 2012-08-06 | 2018-10-18 | Merck Patent Gmbh | Prognosis biomarkers in cartilage disorders |
| CN104736723B (zh) * | 2012-08-06 | 2017-10-31 | 默克专利有限公司 | 用于预测对fgf‑18化合物的响应性的遗传标记 |
| US9829493B2 (en) * | 2013-07-15 | 2017-11-28 | Steven J. Svoboda | Methods and apparatus for assessment of risk for joint injury |
| CA2931978A1 (en) | 2013-12-02 | 2015-06-11 | Abbvie Inc. | Compositions and methods for treating osteoarthritis |
| ES2806026T3 (es) | 2013-12-24 | 2021-02-16 | Ares Trading Sa | Formulación de FGF-18 en hidrogeles de alginato/colágeno |
| KR102622290B1 (ko) | 2013-12-24 | 2024-01-05 | 아레스 트레이딩 에스.아. | 크실로글루칸 겔 중의 fgf-18 제형물 |
| HUE040350T2 (hu) | 2014-02-20 | 2019-03-28 | Merck Patent Gmbh | FGF-18 vegyületadagoló étrend |
| MX2016010873A (es) | 2014-02-20 | 2016-11-17 | Merck Patent Gmbh | Factor de crecimiento de fibroblastos 18 en los procedimientos para el trasplante de injertos y para ingenieria de tejidos. |
| JP6510547B2 (ja) | 2014-02-20 | 2019-05-08 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | Ｆｇｆ−１８を含むインプラント |
| AU2016211950A1 (en) | 2015-01-29 | 2017-07-13 | Ares Trading S.A. | Immunoassays for high positively charged proteins |
| MX380092B (es) | 2015-11-06 | 2025-03-11 | Samumed Llc | Tratamiento de la osteoartritis. |
| US9983214B2 (en) | 2016-04-15 | 2018-05-29 | Esm Technologies, Llc | Method for evaluating articular joint therapeutics |
| SI3688468T1 (sl) | 2017-09-29 | 2022-08-31 | Merck Patent Gmbh | Vnetni biomarkerji za predvidevanje odzivov na spojino FGF-18 |
| IL273613B2 (en) * | 2017-09-29 | 2026-02-01 | Merck Patent Gmbh | Metabolic biomarkers for predicting response to FGF-18 compound |
| IL281333B2 (en) | 2018-09-10 | 2025-11-01 | Merck Patent Gmbh | A method for reducing risk in a clinical trial |
-
2018
- 2018-09-28 IL IL273613A patent/IL273613B2/en unknown
- 2018-09-28 CA CA3076029A patent/CA3076029A1/en active Pending
- 2018-09-28 US US16/650,881 patent/US11513128B2/en active Active
- 2018-09-28 SI SI201830686T patent/SI3687558T1/sl unknown
- 2018-09-28 DK DK18782014.7T patent/DK3687558T3/da active
- 2018-09-28 RS RS20220558A patent/RS63293B1/sr unknown
- 2018-09-28 HU HUE18782014A patent/HUE058786T2/hu unknown
- 2018-09-28 WO PCT/EP2018/076395 patent/WO2019063758A1/en not_active Ceased
- 2018-09-28 EP EP18782014.7A patent/EP3687558B1/en active Active
- 2018-09-28 ES ES18782014T patent/ES2918250T3/es active Active
- 2018-09-28 PL PL18782014.7T patent/PL3687558T3/pl unknown
- 2018-09-28 AU AU2018343982A patent/AU2018343982B2/en active Active
- 2018-09-28 JP JP2020518048A patent/JP7791649B2/ja active Active
- 2018-09-28 CN CN201880063185.7A patent/CN111163791A/zh active Pending
- 2018-09-28 LT LTEPPCT/EP2018/076395T patent/LT3687558T/lt unknown
- 2018-09-28 HR HRP20220760TT patent/HRP20220760T1/hr unknown
-
2022
- 2022-09-07 US US17/930,389 patent/US12332251B2/en active Active
-
2024
- 2024-04-12 JP JP2024064931A patent/JP2024105273A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020535436A5 (https=) | ||
| Martinez et al. | Treatment of acute portal vein thrombosis by nontraditional anticoagulation | |
| Largeau et al. | TSPO PET imaging: from microglial activation to peripheral sterile inflammatory diseases? | |
| Broz et al. | Neuropilin (NRPs) related pathological conditions and their modulators | |
| JP2020535423A5 (https=) | ||
| JP2015513524A5 (https=) | ||
| RU2016147398A (ru) | Способы оценивания и лечения острого миелоидного лейкоза | |
| NO160114B (no) | Blanding for bruk ved ekstern paavisning og lokalisering av blodpropp. | |
| JP2016524592A5 (https=) | ||
| IL201778A0 (en) | Peptide imaging agents | |
| JP2019528285A5 (https=) | ||
| JP2017517507A5 (https=) | ||
| HRP20191145T1 (hr) | Postupak predviđanja ishoda liječenja s afliberceptom kod pacijenta za kojeg se sumnja da ima rak | |
| ES3037703T3 (en) | Blood plasma and plasma fractions as therapy for tumor growth and progression | |
| JP2010500006A5 (https=) | ||
| CA2819080A1 (en) | Agtr1 as a marker for bevacizumab combination therapies | |
| Ebrahimi et al. | Dengue fever in Iran: A case report | |
| CN105801700A (zh) | 抗单核细胞白血病相关抗原MLAA-34全人源单克隆单链抗体ScFv | |
| RU2014123166A (ru) | Восприимчивость к ингибиторам ангиогенеза | |
| RU2016102202A (ru) | Биологический маркер опухоли | |
| JP2019515035A5 (https=) | ||
| RU2014110271A (ru) | Восприимчивость к ингибиторам ангиогенеза | |
| Pérez-Martínez et al. | Magnetic resonance imaging and immunohistochemistry of primary vertebral hemangiosarcoma in a dog and implications for diagnosis and therapy | |
| Smaili et al. | CALR gene mutational profile in myeloproliferative neoplasms with non-mutated JAK2 in Moroccan patients: A case series and germline in-frame deletion | |
| CN107987147A (zh) | 一种mg53多聚体制备方法及其用途 |